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SUMMARY 
Hepatitis C virus (HCV) core protein, expressed with a Semliki forest virus (SFV) replicon, 
self-assembles into HCV-like particles (HCV-LP) at the endoplasmic reticulum (ER) 
membrane, providing an opportunity to study HCV assembly and morphogenesis by electron 
microscopy. We used this model to investigate whether the processing of the HCV core 
protein by the signal peptide peptidase (SPP) is required for the HCV-LP assembly. We 
designed several mutants as there are conflicting reports concerning the cleavage of mutant 
proteins by SPP. Production of the only core mutant protein that escaped SPP processing led 
to the formation of multiple layers of electron-dense ER membrane, with no evidence of 
HCV-LP assembly. Our data shed light on the HCV core residues involved in SPP cleavage 
and suggest that this cleavage is essential for HCV assembly. 
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The hepatitis C virus (HCV) genome contains approximately 9,600 nucleotides. At both the 
5’ and 3’ ends, untranslated regions flank a single open reading frame encoding a single 
polyprotein precursor of about 3,000 amino acids (aa). This precursor is co- and post-
translationally processed by cellular and viral proteases, to yield three mature structural 
proteins [one core (C) and two envelope (E1 and E2) proteins] and six non-structural proteins 
involved in polyprotein processing and viral RNA replication (Grakoui et al., 1993). The 
hydrophobic sequence at the junction between the HCV core protein and the envelope 
glycoprotein E1 (amino acids 170 to 191 in the polyprotein) functions as a signal sequence 
and targets the nascent polyprotein to the ER membrane, inducing the translocation of E1 into 
the lumen of the ER (Lo et al., 1995). Cleavage by a signal peptidase in the ER lumen 
releases the N-terminal end of E1, leaving the 191-aa core protein anchored by the signal 
peptide (McLauchlan 2000). This 191-aa polypeptide (p23) is an immature form of the core 
protein, and is further processed by an intramembrane presenilin-type aspartic protease SPP 
(for signal peptide peptidase) (Weihofen et al., 2002). The site of the SPP cleavage is unclear 
but probably lies between residues 173 and 179, resulting in the elimination from the mature 
core protein of all or part of the N-terminal hydrophobic domain containing the signal peptide 
of E1 (McLauchlan et al., 2002). The resulting mature HCV core protein (p21) is thought to 
constitute the HCV capsid and therefore to be an integral component of the virion. Indeed, 
this mature form of the HCV core protein is the predominant form detected in virus particles 
purified from the sera of patients with chronic HCV infection (Yasui et al., 1998). However, 
processing of the HCV core protein by SPP has also been shown to release the core protein 
from the ER membrane leading to its trafficking to zones of the ER in which lipid droplets are 
produced (McLauchlan et al., 2002). During its trafficking, the proline-rich, central 
hydrophobic domain 2 of the HCV core protein (amino acids 119 to 173) is though to remain 
anchored in the cytoplasmic phospholipid monolayer of the ER, and is therefore thought to be 
present in the membrane surrounding the lipid droplets, which consists of a single 
phospholipid monolayer (Hope & McLauchlan, 2000).  
 
Thus, retention of the HCV core protein in the ER membrane by its sequence signal may play 
an essential role in viral particle assembly by, at least transiently, preventing trafficking to the 
lipid droplets. It therefore remains unclear whether HCV core protein cleavage by SPP is an 
essential step for virion assembly and morphogenesis. Recent advances in the establishment 
of cell culture systems have made it possible to produce infectious HCV that can be 
efficiently propagated in cultured, naive hepatoma cells (Lindenbach et al., 2005; Wakita et 
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al., 2005; Zhong et al., 2005). However, it remains extremely difficult to observe virus 
assembly and morphogenesis in these cell cultures (P.R., personal observations). We have 
developed a model based on Semliki forest virus (SFV) replicon vectors, in which the 
production of the HCV core protein in mammalian cells leads to the assembly of this protein 
into HCV-like particles (HCV-LP) (Blanchard et al., 2003). This model displays abortive 
HCV-LP budding, but it remains a useful tool for studies of the early events of HCV 
assembly in eukaryotic cells (Roingeard et al., 2004).  In this study, we use this
 
HCV capsid 
assembly model to characterise
 
the role of SPP cleavage in viral morphogenesis.  
 
HCV core mutants. Previous studies have identified various residues in the transmembrane 
signal sequence domain of the HCV core protein that are involved in the intramembrane 
cleavage of this protein by SPP. It was initially demonstrated that the ASC180/3/4VLV HCV 
mutant core protein, which contains helix-favouring residues in place of the helix-bending 
and helix-breaking residues, was not processed by SPP (Lemberg & Martoglio, 2002; 
McLauchlan et al., 2002). However, a recent study of the same ASC180/3/4VLV mutant 
demonstrated efficient cleavage of this molecule by SPP (Okamoto et al., 2004). In the same 
study, it was shown that an IF176/7AL core mutant protein was not processed by SPP. These 
discrepancies were observed for the core proteins of both the 1a and 1b genotypes of HCV. 
They were not due to differences in the core protein sequence or in cell type, as both studies 
were conducted with BHK-21 cells. We therefore designed SFV replicon vectors encoding 
the ASC180/3/4VLV and IF176/7AL core mutants, to resolve these discrepancies and to 
address our own research questions. The SF173/4ML mutant core protein was found not to be 
processed by SPP in a third study (Yamanaka et al., 2002), and was therefore also 
investigated in our study. The C191 and C173 sequences were subcloned in SFV vectors from 
the HCV cDNA Dj 6.4 clone (genotype 1a) as previously described (Blanchard et al., 2003). 
Site-directed mutagenesis within the C-terminal C191 signal sequence was performed with 
antisense primers leading to (i) generation of the three mutants ASC180/3/4VLV, IF176/7AL 
and SF173/4ML (Fig. 1A) and (ii) insertion of a stop codon at the 3’ end of the core protein-
coding region.  
 
Cleavage of HCV wild-type and mutant core proteins by SPP. The BHK 21 cell line was 
cultured and electroporated as previously described (Blanchard et al., 2002). SDS-PAGE and 
western blotting analysis showed that the wild-type (WT) C191 core protein was fully cleaved 
by SPP in these cells, as previously reported (Blanchard et al., 2003) (Fig. 1B). In cells 
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transfected with the WT C191 construct and treated with various concentrations (60 µM, 100 
µM or 150 µM) of (Z-LL)2-ketone (Calbiochem), SPP cleavage was partially inhibited (Fig. 
1B), as reported in previous studies using this commercially available SPP inhibitor 
(Weihofen et al., 2003). We used Image J gel analyser software to determine the amounts of 
p23 and p21 forms of HCV core protein in the scanned blots. Uncleaved and cleaved forms 
were detected in equal quantities in cells treated with 60 M of (Z-LL)2-ketone. Similar 
quantities of uncleaved (60%) and cleaved (40%) forms were detected at concentrations of 
100 M and 150 M of (Z-LL)2-ketone, indicating that this protease inhibitor was most 
efficient at a concentration of 100 M (Fig. 1B). This is not surprising, as this compound is 
very efficient in cell-free translation/translocation assays, but less efficient in cellular assays 
because it does not readily cross the plasma membrane (Weihofen et al., 2003).  
 
The ASC180/3/4VLV mutant core protein was the only mutant protein studied that remained 
uncleaved, resulting in detection of the p23 form of the core protein alone (Fig. 1B). This 
confirms the results obtained by Martoglio’s group with this mutant (Lemberg & Martoglio, 
2002; McLauchlan et al., 2002), but conflicts with the data reported by Okamoto et al. (2004). 
We found that the IF176/7AL mutant core protein was efficiently processed by SPP, leading 
to detection of the p21 core protein (Fig. 1B), despite a previous report of this protein being 
resistant to SPP cleavage (Okamoto et al., 2004). The SF173/4ML mutant core protein was 
also efficiently cleaved in our study (Fig. 1B). A total lack of processing (Yamanaka et al., 
2002), or partial processing (Liu et al., 1997) had previously been reported for this protein. 
However, it should be pointed out that mutations in the HCV core protein have been shown to 
have a significant effect on the mobility of this protein in SDS-PAGE (McLauchlan et al., 
2002). In addition, we cannot rule out the possibility that SPP processes the signal sequence 
of the core protein heterogeneously, at several sites, as observed for -secretase, an aspartic 
protease closely related to SPP that cleaves the transmembrane region of the amyloid- 
precursor protein at several sites (Edbauer et al., 2003). These factors may account for 
difficulties in interpreting SDS-PAGE results for HCV mutant core proteins, and highlight the 
need for comparisons with relevant reference peptides. It should be also noted that the 
interaction of the HCV mutant core proteins with lipid droplets was not investigated in most 
of these previous studies. This led us to investigate the subcellular distribution of our HCV 
mutant core proteins. 
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Subcellular distribution of the HCV wild-type and mutant core proteins. This analysis 
was made with the WT and mutant constructs expressed in the human hepatoma FLC4 cell 
line (Aizaki et al., 2003) (Fig. 1C). Expression from SFV vectors was found to be less 
efficient in this cell line than in BHK-21 cells, allowing a more precise analysis of the 
subcellular core distribution and lipid droplet interaction. All the core proteins except the 
ASC180/3/4VLV mutant core protein were colocalized with lipid droplets (Fig. 1C). Nile red 
labeling in control cells transfected with -Gal SFV RNA showed that lipids were evenly 
distributed throughout the cytoplasm. Transfection with the HCV WT C191 and C173 
construct induced the clustering in the perinuclear area of large lipid droplets staining strongly 
for HCV core protein (Fig. 1C). The IF176/7AL and SF173/4MLmutant core proteins had a 
subcellular distribution similar to that of WT C191 (Fig. 1C). The ASC180/3/4VLV mutant 
core protein was weakly associated with some lipid droplets, but was mostly distributed in 
reticular patches throughout the cytoplasm (Fig. 1C). Thus, all the HCV core mutant proteins 
cleaved by SPP in SDS-PAGE analysis were colocalized with lipid droplets, like the WT core 
protein. This confirmed that the ASC180/3/4VLV mutant core protein was the only mutant 
core protein that escaped SPP processing.  
 
Ultrastructural changes induced by the HCV wild-type and mutant core proteins. This 
study is the first to report the ultrastructural changes induced in cells by production of the 
HCV mutant core proteins ASC180/3/4VLV, IF176/7AL and SF173/4ML. BHK-21 cells 
transfected with the recombinant SFV RNAs encoding the two mutant HCV core proteins 
correctly cleaved by SPP (IF176/7AL and SF173/4ML) differed markedly in terms of 
ultrastucture (Fig. 2). As expected, the SF173/4ML mutant core protein gave a pattern similar 
to that of WT C191, with convoluted ER membranes displaying HCV-LP assembly (Fig. 2). 
Conversely, cells producing the IF176/7AL mutant core protein showed no sign of ER 
modification (Fig. 2), like cells transfected with -Gal RNA or C173 RNA. This provides 
additional evidence that this mutant core protein is efficiently cleaved by SPP, and does not 
remain anchored in the ER membrane by its transmembrane sequence signal. This finding 
may also suggest that amino acids 176 and 177 (IF in the WT core protein) are located in the 
mature core protein after SPP cleavage and their replacement by other amino acids may 
hamper core protein multimerization.  
 
Cells transfected with the recombinant SFV RNA encoding the ASC180/3/4VLV mutant 
HCV core protein, which is not processed by SPP, had a very unusual ultrastructure. Indeed, 
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convoluted electron-dense ER membranes were found to form multiple layers in these cells 
(Fig. 3). No HCV-LPs or marked clustering of lipid droplets was observed in cells producing 
this mutant core protein. These observations confirm that the ASC180/3/4VLV core protein 
remains anchored in the ER membrane by its transmembrane sequence signal. This 
unprocessed mutant protein therefore probably displays self-interaction, inducing the 
formation of multi-layer ER membranes, but not assembly to give HCV-LP. These data 
suggest that processing of the HCV core protein by SPP is required for assembly of the virus 
particle. We investigated the ultrastuctural changes induced in cells by production of the WT 
C191 core protein in the presence of (Z-LL)2–ketone. Unfortunately, this commercially 
available SPP inhibitor is not very efficient in cellular assays, due to low plasma membrane 
permeability (Weihofen et al., 2003). We were able to achieve only 60% inhibition of SPP in 
cells transfected with the WT C191 core protein construct and treated with 100 m 
concentration (Z-LL)2–ketone. This treatment decreased the frequency of HCV-LP, which  
became much harder to detect, and led to the generation of multi-layer ER membranes similar 
to those found in cells producing the ASC180/3/4VLV mutant core protein (data not shown). 
Thus, cleavage of the transmembrane signal sequence of the HCV core protein by SPP 
appears to be an essential step in assembly of the viral particle. This conclusion is at odds 
with the recent results of analyses of WT C191 production in yeast cells (Majeau et al., 2005). 
The reasons for these discrepancies are unknown but may be due to differences in the HCV 
assembly mechanisms in yeast and mammalian cells. However, the intracellular HCV-LP 
assembly has not been well established by EM in yeast cell sections.  
 
In conclusion, HCV core protein processing by SPP is required for the trafficking of the 
protein to the lipid droplets, but we suggest that it is also required for assembly into virus 
particles at the ER membrane. Our data provide new insight into the relevance of interactions 
between HCV and host cell factors, and suggest that SPP inhibitors are of potential value for 
the treatment of HCV infection. 
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Fig. 1. Analysis of HCV core-E1 signal peptide processing. (a) Signal sequences of WT C191 
HCV core protein and mutants (IF176/7AL, ASC180/3/4VLV and SF173/4ML). The 
transmembrane region of the signal sequence is underlined. (b): Production in BHK-21 cells 
of the WT and mutant C191 proteins and analysis of their processing by SDS-PAGE and 
western blotting, using the human monoclonal anti-HCV core antibody B12F8 (Esposito et 
al., 1995). The mutants were compared with the WT C191 protein in the absence or presence 
of various concentrations of the SPP inhibitor (Z-LL)2–ketone, and with the reference core 
protein C173. (c). Immunofluorescence of WT and mutant HCV core proteins combined with 
Nile Red staining of lipid droplets in FLC4 cells.  
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Fig. 2. Electron micrographs of BHK-21 cells electroporated with WT C191 (a & b), C191 
SF173/4ML (c & d), or C191 IF176/7AL (e & f) RNA. Micrograph in a shows a zone of 
convoluted ER membranes (delimited by arrowheads) in which HCV-LP assembly (arrows) 
was frequent. Micrograph in b shows that clusters of large lipid droplets were found in the 
perinuclear area next to ER membranes in which HCV-LP assembly (large black arrows) was 
detected. Cells transfected with C191 SF173/4ML RNA presented a pattern similar to that of 
the WT protein, with convoluted ER membranes (delimited by arrowheads in c) in which 
HCV-LP assembly (arrows in d) was detected. Cells transfected with C191 IF176/7AL RNA 
had normal ER structures, evenly distributed throughout the cytoplasm (white arrows), in 
which no HCV-LP was detected, as for cells transfected with -Gal recombinant RNA (not 
shown). The only subtle change in ultrastructure of cells producing C191 IF176/7AL was the 
clustering of lipid droplets in the perinuclear area, next to normal ER membranes (micrograph 
in f). N, nucleus. ld: lipid droplet. ER lu: ER lumen. Bars in a and d, 0,2 m. Bars in b, c, e 
and f, 1 m. 
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Fig. 3. Electron micrographs of BHK-21 cells electroporated with the C191 ASC180/3/4VLV 
RNA, showing electron-dense ER membranes (delimited by arrowheads at low magnification 
in a). At high magnification (c), these structures were found to be formed by the interaction of 
multiple ER membranes (arrow). In b, an immunogold labeling with anti-core antibodies 
demonstrated the presence of high amount of core protein in these multi-layered ER 
membranes. m. Bars in b and c, 100 nm. 
 
 
 
